Nuzenio

Artiva Therapeutics

Artiva Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 2 publisher sources 100/100 entity strength

Timeline

Fri, 07 Aug 2026 11:26:32 GMTArtiva Biotherapeutics, Inc. (ARTV) stock price, news, quote and history - Yahoo Finance UK
Fri, 07 Aug 2026 10:59:49 GMTArtiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41 - TipRanks
Fri, 07 Aug 2026 10:33:21 GMTArtiva Therapeutics: Buy Rating Reiterated on Promising RA Data, Clear Phase 3 Path and Maintained $35 Price Target - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Artiva Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.